XPhyto Therapeutics Corp.: XPhyto Completes Rotigotine Transdermal Patch Optimization and Comparative Skin Absorption Study

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / October 11, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to provide a product development

Related Keywords

Germany ,Biberach ,Baden Wüberg ,United States ,Canada ,Uttenweiler ,Vancouver ,British Columbia ,America ,Canadian ,German ,Hugh Rogers ,Xphyto Rotigotine ,Xphyto Therapeutics Corp ,Wissen Market Research ,Company Rotigotine ,Kuick Research ,Precedence Research ,Vektor Pharma ,North America ,Market Regulator ,Xphyto ,Herapeutics ,Orp ,Ompletes ,Otigotine ,Transdermal ,Watch ,Ptimization ,Comparative ,Skin ,Absorption ,Study ,